Related Experiment Video
Updated: Jul 25, 2025
07:35
Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
Published on: April 25, 2014
12.8K
Exploring potential applications of measles and rubella microarray patches (MR-MAPs): use case identification
Stefano Malvolti1, Melissa Ko1, Marion Menozzi-Arnaud2
1MMGH Consulting GmbH, Zurich, Switzerland.
Frontiers in Public Health
|June 28, 2023
Summary
Innovative measles and rubella (MR) microarray patches (MAPs) offer a needle-free solution to improve vaccine coverage and achieve global immunization goals. Six key use cases were identified to guide the equitable delivery of MR-MAPs in diverse health programs.
Area of Science:
- Vaccinology
- Public Health
- Health Technology
Background:
- Measles and rubella (MR) vaccine coverage targets remain unmet due to implementation barriers.
- Innovative vaccine delivery systems are crucial for achieving global immunization goals, such as the "Immunization Agenda 2030".
Purpose of the Study:
- To define potential use cases for measles and rubella (MR) microarray patches (MAPs) within immunization programs.
- To identify critical attributes for MR-MAPs to inform product development and policy decisions.
Main Methods:
- A user-centric approach was employed, involving a three-step process.
- This process included a desk review, a survey, and expert interviews to define use cases.
Main Results:
- Six use cases for MR-MAPs were identified and validated by experts.
- These use cases are applicable across various countries and immunization program designs.
Conclusions:
- The identified use cases for MR-MAPs will inform demand estimations and value assessments.
- Defining use cases is critical for maximizing the impact of MR-MAPs, especially in underserved populations.
